US EditionPublished • loading... • Updated
Ftse 100 Leads Charge Amid Sea of Green Across Europe: Gsk Ceo, Astraz
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
FTSE Share Prices Climb As Healthcare Momentum Meets US Data Focus
In London, the FTSE 100 edged closer to its record highs, lifted by renewed interest in drugmakers implementing fresh strategic shifts. One heavyweight saw double-digit moves intraday after a trial result from a rival threw doubts across an entire therapeutic area. Meanwhile, in the UK, GSK’s share price leapt on news of a CEO transition and AstraZeneca also found fresh wind via plans to align its global listings and encouraging clinical updates…
The London FTSE index rose 0.54 percent to 9,335 points, while Frankfurt's DAX rose 0.21 percent to 23,789 points, and the Paris CAC rose 0.23 percent to 7,888 points.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
